Interview with Dr. Mike Jones, MD of Impact Minerals Ltd.

Our previous interview: https://www.cruxinvestor.com/posts/impact-minerals-asxipt-pitch-perfect-october-2025-8328

Recording date: 8th June 2026

Impact Minerals Limited (ASX:IPT) is undergoing a deliberate and material transformation. What began as a junior mining explorer is becoming, under the direction of Managing Director Dr. Mike Jones, a specialty chemicals and material science company with a credible path to producing high-purity alumina which is a critical input for battery separators, artificial sapphire, advanced ceramics, and semiconductor components.

The company's commercial strategy rests on two interconnected assets. The first is a 50% stake in Alluminous, which holds a patented solvent extraction process for producing HPA from widely available chemical feedstock. That intellectual property is now protected across the United States, Canada, and Southeast Asia, jurisdictions that management views as the primary commercialisation markets. The second is the Lake Hope clay project in Western Australia, where a Pre-Feasibility Study has been completed and work toward a Definitive Feasibility Study is underway.

What has sharpened investor attention recently is a process engineering breakthrough at the Alluminous pilot plant. By modifying the orientation of impellers in the solvent extraction stage, the team achieved up to ten times the originally designed throughput. Dr. Jones has stated that this discovery could allow the company to reach production capacity comparable to its listed peers for under AU$10 million in capital — against the AU$200 million-plus spent by those peers to reach similar output levels. The scoping study for a 2,000-tonne-per-annum commercial plant is expected to provide independent cost validation shortly, making it one of the most significant near-term catalysts for the stock.

The competitive context is instructive. Alpha HPA carries a market capitalisation of approximately AU$650–700 million. Advanced Energy Minerals trades at approximately AU$250–300 million. Both began as resource companies and have re-rated substantially as they have moved toward production. Impact Minerals currently sits at a significant discount to both, at a stage where the technology has been proven in batch mode, IP is protected, and initial customer engagement — including 3kg sapphire-grade samples dispatched to European buyers — is underway.

The market entry strategy is measured. Rather than chasing premium 5N pricing immediately, management has chosen to enter the higher-volume 3N advanced ceramics segment first, building commercial credibility before moving up what Dr. Jones calls the "pyramid of purity." This approach mirrors the path taken by peers and reduces the risk of prolonged customer qualification timelines.
The company's byproduct streams add further resilience to the investment case. Potash which is almost entirely imported into Western Australia and aluminium chlorohydrate have both attracted early buyer interest and are the subject of a separate scoping study. A joint venture on these streams would allow Impact to advance its HPA programme without proportional increases in capital expenditure.

The principal risks are clear and should be held alongside the opportunity. Back-end engineering challenges remain unresolved, the technology has not yet been demonstrated at scale, and the company is pre-revenue. However, with patent protection secured, a breakthrough in production efficiency, a clear commercialisation roadmap, and peers trading at valuations ten to twenty times higher, the risk-reward profile at current prices warrants serious investor attention.

View Impact Minerals' company profile: https://www.cruxinvestor.com/companies/impact-minerals